Drug General Information
Drug ID
D07WXT
Former ID
DNC000879
Drug Name
Lithium chloride
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535388], [536546]
Structure
Download
2D MOL

3D MOL

Formula
ClLi
Canonical SMILES
[Li+].[Cl-]
InChI
1S/ClH.Li/h1H;/q;+1/p-1
InChIKey
KWGKDLIKAYFUFQ-UHFFFAOYSA-M
CAS Number
CAS 7447-41-8
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:48607
Target and Pathway
Target(s) Glycogen synthase kinase-3 Target Info Inhibitor [535388], [536546]
NetPath Pathway TGF_beta_Receptor Signaling Pathway
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
Insulin/IGF pathway-protein kinase B signaling cascade
PDGF signaling pathway
Ras Pathway
Pathway Interaction Database Degradation of beta catenin
Canonical Wnt signaling pathway
FOXM1 transcription factor network
Class I PI3K signaling events mediated by Akt
Reactome AKT phosphorylates targets in the cytosol
XBP1(S) activates chaperone genes
Constitutive Signaling by AKT1 E17K in Cancer
References
Ref 535388Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med. 2002 Mar;8(3):126-32.
Ref 536546Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS. J Neuroimmune Pharmacol. 2007 Mar;2(1):93-6. Epub 2006 Dec 16.
Ref 535388Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med. 2002 Mar;8(3):126-32.
Ref 536546Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS. J Neuroimmune Pharmacol. 2007 Mar;2(1):93-6. Epub 2006 Dec 16.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.